Showing results (21-30 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|March 6, 2018
Expressions of IGF-1, ERK, GLUT4, IRS-1 in metabolic syndrome complicated with colorectal cancer and their associations with the clinical characteristics of CRCJianxia Hu, Xiaoyi Liu, Jingwei Chi, et al.Cancer Biomarkers : Section a of Disease Markers|March 6, 2018
The expression of CCL18 in diffuse large B cell lymphoma and its mechanism researchQianping Zhou, Lanshan Huang, Yongyao Gu, et al.Cancer Biomarkers : Section a of Disease Markers|December 12, 2017
The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancerXin-Ran Xu, Xin Wang, Hong Zhang, et al.Cancer Biomarkers : Section a of Disease Markers|November 11, 2017
Adrenalectomy was recommended for patients with subclinical Cushing's syndrome due to adrenal incidentalomaDong Wang, Zhi-Gang Ji, Han-Zhong Li, et al.Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathwayBenxia Yu, Wei Gao, Hui Zhou, et al.Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
Serum miR-542-3p as a prognostic biomarker in osteosarcomaQicai Li, Shirong Song, Guangzhen Ni, et al.Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancerJuanli Ji, Weiguo Zhen, Yuan Si, et al.Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formationJiangcheng Zuo, Yalan Yu, Man Zhu, et al.Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary studyWeronika Świtlik, Michał Seweryn Karbownik, Michał Suwalski, et al.Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer riskJohn D Groopman, Denise Johnson, Thomas W KenslerPageof 192